JPMorgan Chase & Co’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.78M Sell
179,759
-99,663
-36% -$1.54M ﹤0.01% 3126
2025
Q1
$4.16M Buy
279,422
+195,596
+233% +$2.91M ﹤0.01% 2794
2024
Q4
$1.11M Buy
83,826
+40,721
+94% +$539K ﹤0.01% 3734
2024
Q3
$613K Sell
43,105
-14,599
-25% -$208K ﹤0.01% 3906
2024
Q2
$747K Sell
57,704
-15,649
-21% -$202K ﹤0.01% 3661
2024
Q1
$1.02M Buy
73,353
+273
+0.4% +$3.79K ﹤0.01% 3559
2023
Q4
$1.04M Sell
73,080
-219,052
-75% -$3.13M ﹤0.01% 3510
2023
Q3
$4.52M Sell
292,132
-15,399
-5% -$238K ﹤0.01% 2488
2023
Q2
$4.83M Buy
307,531
+233,423
+315% +$3.67M ﹤0.01% 2514
2023
Q1
$1.22M Buy
74,108
+57,166
+337% +$942K ﹤0.01% 3322
2022
Q4
$264K Sell
16,942
-994
-6% -$15.5K ﹤0.01% 4080
2022
Q3
$233K Buy
17,936
+884
+5% +$11.5K ﹤0.01% 4105
2022
Q2
$239K Sell
17,052
-279
-2% -$3.91K ﹤0.01% 4236
2022
Q1
$248K Sell
17,331
-94
-0.5% -$1.35K ﹤0.01% 4343
2021
Q4
$237K Sell
17,425
-1,596
-8% -$21.7K ﹤0.01% 4450
2021
Q3
$311K Sell
19,021
-4,487
-19% -$73.4K ﹤0.01% 4201
2021
Q2
$396K Sell
23,508
-240,346
-91% -$4.05M ﹤0.01% 4125
2021
Q1
$4.82M Buy
263,854
+218,193
+478% +$3.98M ﹤0.01% 2679
2020
Q4
$831K Sell
45,661
-146,619
-76% -$2.67M ﹤0.01% 3472
2020
Q3
$3.49M Buy
192,280
+68,358
+55% +$1.24M ﹤0.01% 2437
2020
Q2
$2.22M Sell
123,922
-56,961
-31% -$1.02M ﹤0.01% 2626
2020
Q1
$2.75M Buy
180,883
+126,646
+234% +$1.92M ﹤0.01% 2398
2019
Q4
$1.07M Buy
54,237
+29,026
+115% +$573K ﹤0.01% 3031
2019
Q3
$433K Sell
25,211
-450
-2% -$7.73K ﹤0.01% 3401
2019
Q2
$450K Buy
25,661
+143
+0.6% +$2.51K ﹤0.01% 3417
2019
Q1
$520K Sell
25,518
-43,660
-63% -$890K ﹤0.01% 3360
2018
Q4
$1.16M Buy
+69,178
New +$1.16M ﹤0.01% 2949